BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: SMAD family member 2 (MADH2; SMAD2); myostatin (GDF8; MSTN)

February 12, 2015 8:00 AM UTC

In vitro and mouse studies suggest that a peptide inhibitor of SMAD2 could help treat Duchenne muscular dystrophy (DMD). Myostatin-induced stimulation of SMAD2 is associated with muscle-wasting diseas...